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Abstract This review focuses on the structure and mode-
of-action of the two-peptide (class-IIb) bacteriocins that
consist of two different peptides whose genes are next to
each other in the same operon. Optimal antibacterial
activity requires the presence of both peptides in about
equal amounts. The two peptides are synthesized as pre-
forms that contain a 15–30 residue double-glycine-type
N-terminal leader sequence that is cleaved off at the
C-terminal side of two glycine residuesby a dedicatedABC-
transporter that concomitantly transfers the bacteriocin
peptides across cell membranes. Two-peptide bacteriocins
render the membrane of sensitive bacteria permeable to a
selected group of ions, indicating that the bacteriocins form
or induce the formation of pores that display speciﬁcity with
respect to the transport of molecules. Based on structure–
function studies, it has been proposed that the two peptides
of two-peptide bacteriocins form a membrane-penetrating
helix–helix structure involving helix–helix-interacting
GxxxG-motifs that are present in all characterized two-
peptide bacteriocins. It has also been suggested that the
membrane-penetrating helix–helix structure interacts with
an integrated membrane protein, thereby triggering a con-
formational alteration in the protein, which in turn causes
membrane-leakage. This proposed mode-of-action is simi-
lar to the mode-of-action of the pediocin-like (class-IIa)
bacteriocins and lactococcin A (a class-IId bacteriocin),
which bind to a membrane-embedded part of the mannose
phosphotransferase permease in a manner that causes
membrane-leakage and cell death.
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Introduction
Bacteria produce ribosomally synthesized antibacterial
polypeptides, generally referred to as bacteriocins [12, 20,
24, 31, 52, 53, 55]. These polypeptides have attracted much
attention due to their potential use as antibacterial agents
for the treatment of infections and preservation of food and
animal feed. There has especially been great interest in the
peptide bacteriocins produced by lactic acid bacteria
(LAB) because of the ‘‘food grade quality’’ and industrial
importance of these bacteria. LAB are used in food and
feed production, they are part of the natural microbial ﬂora
in food humans have consumed for centuries, and they
constitute a signiﬁcant part of the indigenous microbiota of
mammals, including humans. It is therefore considered to
be relatively safe to use these bacteria and the bacteriocins
they produce to prevent the growth of pathogenic/unde-
sirable bacteria [9]. The LAB bacteriocins pediocin PA-1/
AcH and nisin are in fact presently used as food preser-
vatives [11, 12, 15], and the potential of LAB bacteriocins
in medical applications is illustrated by the fact that oral
intake of bacteriocin-producing LAB protects mice against
lethal doses of Listeria monocytogenes [10].
The small heat stable LAB peptide bacteriocins are
divided into two classes.
1 Class-I consists of bacteriocins
(often referred to as lantibiotics) that contain one or more
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1 There is also a third class of LAB bacteriocins (class III), that
consists of a few large heat-labile protein bacteriocins that have
overall not been as extensively characterized as the class I and II
peptide bacteriocins.
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DOI 10.1007/s12602-009-9021-zof the modiﬁed amino acid residues lanthionine, b-methy-
llanthionine, dehydroalanine, dehydrobutyrine, and/or
D-alanine [11, 12], whereas class-II consists of bacteriocins
that lack modiﬁed residues [12, 20, 24, 53, 55]. The class-II
bacteriocins are further divided into four subclasses, class-
IIa,-IIb,-IIc,and-IId[12].Class-IIacontainstheantilisterial
one-peptide pediocin-like bacteriocins that have similar
amino acid sequences [12, 20, 24, 53], class-IIb contains the
two-peptide bacteriocins [12, 31, 53, 55], class-IIc consists
of the cyclic bacteriocins whose N- and C-termini are
covalently linked [12, 53], and class-IId contains the one-
peptide non-cyclic bacteriocins that show no sequence
similarity to the pediocin-like bacteriocins [12, 53].
Developing LAB bacteriocins into agents for treatment of
infections and for preservation of food and animal feed is
clearly of considerable importance due to the alarming
increase in antibiotic-resistant pathogenic bacteria and the
undesirablesideeffectsthatmanychemicalpreservativesmay
have. Rational design of new bacteriocin variants with prop-
erties that make them especially useful for medical and bio-
technologicalapplicationsrequires,however,insightintohow
they function at a molecular level. This in turn necessitates
insightintotheirthree-dimensionalstructures,asbacteriocins
function through structural interactions. In this review on the
two-peptide (class-IIb) bacteriocins, the focus will especially
be on recent structure–function studies that have given us
some insight into the structure of these bacteriocins.
Proteins and Genes Involved in Production of Two-
Peptide Bacteriocins
At least 15 two-peptide (class-IIb) bacteriocins
2 (Fig. 1)
have been isolated and characterized since the ﬁrst isola-
tion of such a bacteriocin (lactococcin G) in 1992 [51]. As
the name suggests, these bacteriocins are unique in that
they consist of two different peptides, and optimal anti-
bacterial activity requires the presence of both peptides in
about equal amounts [31, 53, 55]. The two peptides are
synthesized as preforms that contain a 15–30 residue
N-terminal leader sequence of the so-called double-glycine
type that is cleaved off at the C-terminal side of two gly-
cine residues by a dedicated ABC-transporter that transfers
the bacteriocin across the membrane [37, 38]. The leader
sequence apparently facilitates interaction with the dedi-
cated ABC-transporter and might possibly also function to
keep the bacteriocin inactive until it has been secreted. The
genes encoding the preforms of the two peptides are always
found next to each other in the same operon along with the
gene that encodes the immunity protein that protects the
bacteriocin-producer from being killed by its own bacte-
riocin [53, 55]. For some bacteriocins (such as lactococcin
G), this operon contains also the genes encoding the ded-
icated ABC-transporter and a so-called accessory protein.
For other bacteriocins (such as enterocin 1071, plantaricin
E/F, and plantaricin J/K), the genes encoding the ABC-
transporter and accessory protein are on a separate operon
nearby the operon with the genes encoding the preforms of
the two peptides and the immunity protein. The function of
the so-called accessory protein is not entirely clariﬁed, but
it may be involved in immunity against the bacteriocin and/
or required (along with the dedicated ABC-transporter) for
secretion of the bacteriocin.
Some two-peptide bacteriocins seem to be produced
constitutively, whereas the production of other two-peptide
bacteriocins (such as plantaricin E/F, plantaricin J/K
[16–18], ABP-118 [26] and NC8 [44]) is transcriptionally
regulated through a three-component regulatory system
consisting of a peptide pheromone, a membrane-associated
histidine protein kinase, and response regulators [41]. Upon
secretion from bacteria, the peptide pheromone interacts
with the membrane-associated histidine kinase, thereby
triggering the kinase to phosphorylate the intracellular
response regulator, thus enabling the response regulators to
activate the operon needed for bacteriocin synthesis and
secretion [41].
Plantaricin A is the peptide pheromone that induces the
production of two two-peptide bacteriocins, plantaricin E/F
and plantaricin J/K, from Lactobacillus plantarum C11
[16–18, 34]. Structural analysis of this peptide pheromone
revealed a novel membrane-interacting mechanism
whereby the pheromone (and perhaps other membrane
active peptide pheromones/hormones) functions [42]. It
seems that plantaricin A ﬁrst interacts in a non-chiral
manner with membrane lipids, and that this interaction
induces a-helical structuring in a region of the peptide [42].
The pheromone thereby becomes sufﬁciently structured
and properly positioned in the membrane to subsequently
interact in a chiral manner with the histidine protein kinase
in or near the membrane–water interface.
The Two Peptides of Two-Peptide Bacteriocins
Function as One Antibacterial Unit
A peptide from a two-peptide bacteriocin displays high
antimicrobial activity only when combined with the com-
plementary peptide from the same two-peptide bacteriocin
or in some cases when combined with a peptide from a
homologous two-peptide bacteriocin. For instance, the two
peptides that constitute lactococcin G are active at pico
2 Two-peptide lantibiotics have also been identiﬁed and characterized
[11, 12], but they are allocated to class-I along with the one-peptide
lantibiotics. They are thus not included in Fig. 1 and will not be
discussed in this review.
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123to nano-molar concentrations when combined, but show
no activity when assayed individually at micro-molar
concentrations [49, 51], nor when combined with either the
E- or F-peptide of plantaricin E/F or the J- or K-peptide of
plantaricin J/K [3]. High activity is, however, obtained
when one of the lactococcin G peptides is combined with
the complementary peptide from lactococcin Q or entero-
cin 1071 [54, 55, 67], presumably, because these three two-
peptide bacteriocins show extensive sequence similarities
(about 88 and 57% sequence identity between lactococcin
G and, respectively, lactococcin Q and enterocin 1071;
Fig. 1).
The fact that a peptide from a two-peptide bacteriocin
displays high antibacterial activity only in combination
with the complementary peptide from the same or a
homologous two-peptide bacteriocin clearly indicates that
the two peptides of two-peptide bacteriocins function
together as one antibacterial unit. This is in accordance
with results showing that the genes encoding the two
peptides of two-peptide bacteriocins are always next to
each other on the same operon, and that the two peptides
are thus produced in approximately equal amounts.
Moreover, circular dichroism (CD) structural studies
indicate that the two peptides of two-peptide bacteriocins
interact and structure each other when exposed simulta-
neously to membrane-like entities such as liposomes
[33, 35]. The synergistic action of the two peptides thus
seems to be due to the fact that they interact with each
other and form one antibacterial unit, rather than that they
separately act on two different sites on target cells.
The Two-Peptide Bacteriocins Permeabilize
Target-Cell Membranes
All two-peptide bacteriocins whose mode-of-action has
been studied, this includes plantaricin E/F [50], plantaricin
J/K [50], lactococcin G [48, 49], thermophilin 13 [46],
lactacin F [1], and lactocin 705 [8, 13], render the mem-
branes of sensitive bacteria permeable to small molecules.
The studies revealed that the bacteriocins show speciﬁcity
with respect to which small molecules they conduct across
membranes, and that the bacteriocins differ somewhat in
their speciﬁcities. For instance, lactococcin G permeabi-
lizes target-cell membranes for a variety of monovalent
cations, such as Na
?,K
?,L i
?,C s
?,R b
?, and choline, but
Lactococcin G  LcnG-α 
LcnG-β 
GTWDDIGQGIGRVAYWVGKAMGNMSDVNQASRINRKKKH
KKWGWLAWVDPAYEFIKGFGKGAIKEGNKDKWKNI
[51]
Lactococcin Q  LcnQα 
LcnQβ 
SIWGDIGQGVGKAAYWVGKAMGNMSDVNQASRINRKKKH
KKWGWLAWVEPAGEFLKGFGKGAIKEGNKDKWKNI
[67]
Enterocin 1071 Entα 
Entβ 
ESVFSKIGNAVGPAAYWILKGLGNMSDVNQADRINRKKH
GPGKWLPWLQPAYDFVTGLAKGIGKEGNKNKWKNV
[4, 5, 27] 
Plantaricin E/F  PlnE 
PlnF 
FNRGGYNFGKSVRHVVDAIGSVAGIRGILKSIR
VFHAYSARGVRNNYKSAVGPADWVISAVRGFIHG
[3, 17] 
Plantaricin J/K  PlnJ 
PlnK
GAWKNFWSSLRKGFYDGEAGRAIRR
RRSRKNGIGYAIGYAFGAVERAVLGGSRDYNK
[3, 17] 
Plantaricin S  Plsα 
Plsβ 
RNKLAYNMGHYAGKATIFGLAAWALLA
KKKKQSWYAAAGDAIVSFGEGFLNAW
[39, 63] 
Plantaricin NC8  PLNC8α 
PLNC8β 
DLTTKLWSSWGYYLGKKARWNLKHPYVQF
SVPTSVYTLGIKILWSAYKHRKTIEKSFNKGFYH
[45]
Lactacin F  LafA 
LafX
RNNWQTNVGGAVGSAMIGATVGGTICGPACAVAGAHYLPILWTGVTAATGGFGKIRK
NRWGDTVLSAASGAGTGIKACKSFGPWGMAICGVGGAAIGGYFGYTHN
[2, 29] 
Brochocin-C BrcA 
BrcB
YSSKDCLKDIGKGIGAGTVAGAAGGGLAAGLGAIPGAFVGAHFGVIGGSAACIGGLLGN
KINWGNVGGSCVGGAVIGGALGGLGGAGGGCITGAIGSIWDQW
[47]
Thermophilin 13  ThmA 
ThmB
YSGKDCLKDMGGYALAGAGSGALWGAPAGGVGALPGAFVGAHVGAIAGGFACMGGMIGNKFN
QINWGSVVGHCIGGAIIGGAFSGGAAAGVGCLVGSGKAIINGL
[46]
ABP-118  Abp118α 
Abp118β 
KRGPNCVGNFLGGLFAGAAAGVPLGPAGIVGGANLGMVGGALTCL
KNGYGGSGNRWVHCGAGIVGGALIGAIGGPWSAVAGGISGGFTSCR
[26]
Salivaricin P  Sln1 
Sln2 
KRGPNCVGNFLGGLFAGAAAGVPLGPAGIVGGANLGMVGGALTCL
KNGYGGSGNRWVHCGAGIVGGALIGAIGGPWSAVAGGISGGFASCH
[6]
Mutacin IV  NlmA 
NlmB
KVSGGEAVAAIGICATASAAIGGLAGATLVTPYCVGTWGLIRSH
DKQAADTFLSAVGGAASGFTYCASNGVWHPYILAGCAGVGAVGSVVFPH
[57]
Lactocin 705  705α 
705β 
GMSGYIQGIPDFLKGYLHGISAANKHKKGRLGY
GFWGGLGYIAGRVGAAYGHAQASANNHHSPING
[14]
Fig. 1 Amino acid sequences of the unmodiﬁed (class-IIb) two-
peptide bacteriocins. The GxxxG-motifs are marked with black
background. Plantaricin Sb and plantaricin NC8b have the GxxxG-
like motifs AxxxA- and SxxxS-motif, respectively, instead of the
GxxxG-motif. The recently identiﬁed two-peptide bacteriocin entero-
cin C [43] is not included in the ﬁgure. Its sequence is identical to
enterocin 1071, except that enterocin C has an alanine residue instead
of a threonine residue at position 17 in its b-peptide [43]. The two-
peptide bacteriocins leucocin H [7], lactococcin MN [65], and
lactococcin MMT24 [32] are also not included in the ﬁgure. Leucocin
H has not been completely sequenced, but the partial sequence reveals
a putative GxxxG-motif. Also lactococcin MN has putative GxxxG-
motifs, but is not included in the list, since only the sequences of the
preforms are known, and the cleavage site is unknown. Lactococcin
MMT24 has not been sequenced. The ﬁgure is a modiﬁed version of
Fig. 1 in Ref. [56]. References for the sequences are indicated in the
ﬁgure, and are as follows: lactococcin G [51], lactococcin Q [67],
enterocin 1071 [4, 5, 27], plantaricin E/F and J/K [3, 17], plantaricin S
[39, 63], plantaricin NC8 [45], lactacin F [2, 29], brochocin C [47],
thermophilin 13 [46], ABP-118 [26], salivaricin P (differs from ABP-
118 in only two residues) [6], mutacin IV [57], and lactocin 705 [14]
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123not for H
?, nor divalent cations such as Mg
2? or anions
such as phosphate [48, 49]. Plantaricin E/F and plantaricin
J/K permeabilize membranes for monovalent ions,
including H
? (in contrast to lactococcin G), but not for
divalent ions such as phosphate and Mg
2? [50]. It appears,
however, as if plantaricin J/K conducts anions more efﬁ-
ciently than plantaricin E/F and vice versa for cations [50].
Lactacin F renders membranes permeable to K
? and
phosphate [1], and thermophilin 13 has been shown to
dissipate both the trans-membrane electrical potential and
pH gradient, but its speciﬁcity with respect to molecules it
conducts across membranes has not been studied [46]. This
ability to differentiate between molecules they transport
across membranes indicates that these two-peptide bacte-
riocins form (or induce the formation of) relatively
sophisticated pores that display speciﬁcity with respect to
transport of molecules, rather than induce membrane-
leakage through a detergent-like disruption of membranes.
Moreover, the high potency of the two-peptide bacteriocins
suggests that membrane permeabilization depends on a
relative low number of peptides, unlike what is expected if
permeabilization is due to a detergent-like disruption of
membranes.
The Structure of Two-Peptide Bacteriocins
CD and NMR structural studies have been carried out on the
three two-peptide bacteriocins lactococcin G, plantaricin
E/F, and plantaricin J/K [25, 33, 35, 58, 59]. CD studies
show that the peptides of these three bacteriocins are
unstructured, with no structural interactions between com-
plementary peptides, when in aqueous solution. Helical
structuring occurs, however, when the peptides are indi-
vidually exposed to a more hydrophobic or membrane-like
environment, such as when the peptides are in solutions
containing triﬂuoroethanol (TFE), micelles or liposomes
[25, 33, 35, 58, 59]. Moreover, additional structuring is
obtained when complementary peptides are mixed and then
exposed to membrane-like entities such as liposomes,
indicating that the peptides interact in a structure-inducing
manner upon contact with target-membranes [33, 35]. It
seems that the target-membrane must have a reasonable ﬂat
surface (i.e., liposomes or bilayers) for the inter-peptide
interaction to take place, since the additional structuring is
not observed in the presence of micelles.
All two-peptide bacteriocins identiﬁed so far contain
GxxxG-motifs (Fig. 1). This motif is signiﬁcantly over-
represented in transmembrane helices and it is, along with
the ‘‘GxxxG-like’’ motifs AxxxA and SxxxS, known to
mediate helix–helix interactions in membrane proteins
[60–62]. When in an a-helix, the two glycine residues in
the motif will be on the same side of the helix and thereby
create a ﬂat interaction site that allows close inter-helical
contact, thereby enabling optimal inter-helical van der
Waals interactions and formation of stabilizing inter-heli-
cal backbone Ca–H
…O hydrogen bonds [62].
The presence of GxxxG-motifs and a high helical con-
tent suggests that the peptides of two-peptide bacteriocins
form membrane-penetrating helix–helix structures involv-
ing their GxxxG-motifs. Such helix–helix structuring
would generate and/or stabilize helical structuring in the
somewhat ﬂexible GxxxG-motifs and possibly also in other
ﬂexible segments in the two complementary peptides, and
this could explain the increased helical content observed by
CD spectroscopy when complementary peptides are
simultaneously exposed to target-membranes.
Structure and Membrane-Orientation of Lactococcin G
Lactococcin G is perhaps the two-peptide bacteriocin that
is best characterized [35, 48, 49, 51, 54, 56, 58]. It consists
of the 39 residue a-peptide (often termed LcnG-a) and the
35 residue b-peptide (often termed LcnG-b) (Fig. 1). NMR
structural studies revealed a-helices in both the N- (resi-
dues 3–21) and C- (residues 24–34) terminal halves of the
a-peptide in the presence of either DPC micelles or TFE
[58]. Helices were also found in the N- (residues 11–19)
and C- (residues 23–32) terminal halves of the b-peptide in
the presence of TFE, but only one helix, in the N-terminal
half, was observed in the presence of DPC [58].
The a-peptide has two GxxxG-motifs (Gly-7 to Gly-11
and Gly-18 to Gly-22; Fig. 1), and the b-peptide has
one (Gly-18 to Gly-22; Fig. 1). The GxxxG-motif in the
b-peptide and the ﬁrst one (G7xxxG11) in the a-peptide are
also found in lactococcin Q and enterocin 1071 (Fig. 1),
two bacteriocins that have extensive sequence similarity
with lactococcin G. This suggests that these two GxxxG-
motifs are of special importance for the functioning of
lactococcin G, lacococcin Q, and enterocin 1071, and it has
been postulated that the a- and b-peptides of these three
bacteriocins interact through helix–helix interactions
involving these two GxxxG-motifs. Indeed, replacement of
the glycine residues in these GxxxG-motifs with larger
residues that interfere with close helix–helix contact was
highly detrimental, consistent with these motifs being
involved in helix–helix interactions [56]. Replacement of
the other glycine residues in the peptides was, in contrast,
relatively well tolerated [56].
Based on site-directed mutagenesis studies (discussed in
the three subsequent paragraphs) and the NMR structure of
the a- and b-peptides, a structural model of lactococcin G
has been proposed [53, 56, 58]. The proposed structure
should also be valid for enterocin 1071 and lactococcin Q,
since their sequence similarities to lactococcin G indicate
that these three bacteriocins have similar three-dimensional
Probiotics & Antimicro. Prot. (2010) 2:52–60 55
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entails that the a- and b-peptides are oriented in the same
direction and form a staggered helix–helix structure that
spans the target-cell membrane (Fig. 2)[ 53, 56, 58]. The
helix–helix segment consists of the N-terminal half of the
a-peptide (from about residue 3 to residue 22) and the
C-terminal half of the b-peptide (from about residue 13 to
residue 32). The structural model also entails that the
strikingly cationic C-terminal end (residues 35–39: R–K–
K–K–H) of the a-peptide is unstructured and forced
through the target-cell membrane by the membrane
potential (negative inside), thereby positioning the C-ter-
mini of the two peptides inside the target-cell (Fig. 2). The
tryptophan-rich N-terminal end of the b-peptide is also
proposed to be relatively unstructured and to position itself
in the outer membrane interface, thus forcing the N-termini
of the two peptides to remain on the outer side of the
target-cell membrane and the helix–helix segment to
transverse the membrane (Fig. 2). The proposed helix–
helix interaction will structure the ﬂexible G18xxxG22-
motif in the b-peptide and thereby prolong the main helix
from residue 19 to at least residue 22. The helix–helix
interaction may also generate and/or stabilize helical
structuring in other regions as well, such as between resi-
dues 21 and 24 (which is part of the second GxxxG-motif)
in the a-peptide and thereby prolong the main helix in the
a-peptide to residue 34. This may explain the increased
helicity observed by CD spectroscopy when complemen-
tary peptides are mixed together and exposed to target-
membranes [33, 35].
The four C-terminal residues in the a-peptide and four of
the ﬁve N-terminal residues in the b-peptide can be
replaced with the corresponding D-isomeric residues
without a high reduction in the antibacterial activity (Op-
pega ˚rd, Rogne, unpublished results). The C- and N-termi-
nal region of, respectively, the a- and b-peptide are thus not
highly structured nor involved in inter-peptide interac-
tions—consistent with the proposed structure. Also the
replacement of any one of the three tryptophan residues
(Trp-3, Trp-5 and Trp-8) in the structurally ﬂexible
N-terminal region of the b-peptide with an aromatic (Phe,
Tyr), hydrophobic (Leu), or hydrophilic (Arg) residue is
relatively well tolerated, indicating that this region is not
embedded in a strictly hydrophobic or hydrophilic envi-
ronment [56]. In accordance with the proposed structure,
this suggests that the region is in fact embedded in the
membrane interface, thus enabling the side chains of the
hydrophilic and hydrophobic residues to ‘‘snorkel’’ into
the, respectively, hydrophilic and hydrophobic regions of
the membrane.
Also consistent with the proposed structure (which
entails that the N-termini of the peptides face the cells
outside) are results showing that fusion proteins consisting
of the immunoglobulin-binding domain of streptococcal
protein G linked to the N-terminal residue of either the
a-o rb-peptide exhibit antibacterial activity in combination
with the complementary peptide. Although the activity was
reduced dramatically (about 20,000-fold reduction for the
fused a-peptide and 5,000-fold reduction for the fused
b-peptide), the results suggest that the N-terminal part of the
peptides does not penetrate through the target-cell mem-
brane (P. Rogne and C. Oppega ˚rd, unpublished results).
One conspicuous difference between the homologous
bacteriocins lactococcin G, lactococcin Q, and enterocin
1071 is that the latter bacteriocin has a negative charge
(which is absent in lactococcin G and lactococcin Q) at the
N-terminus of the a-peptide, whereas lactococcin G and
lactococcin Q have a negative charge (which is absent in
enterocin 1071) at position 10 in the b-peptide (Fig. 1).
Site-directed mutagenesis studies has revealed that the
detrimental effect of removing the N-terminal negative
charge in the a-peptide of enterocin 1071 is neutralized by
introducing a negative charge at position 10 in the b-pep-
tide of enterocin 1071 [54]. The negative charge in residue-
1 in the a-peptide (as in enterocin 1071) thus appears to be
functionally equivalent to a negative charge in residue-10
in the b-peptide (as in lactococcin G and lactococcin Q).
The proposed structure may account for this, since residue-
1 in the a-peptide and residue-10 in the b-peptide are near
each other in the proposed structure (Fig. 2). The proposed
structure may also explain mutagenesis results showing
that the lactococcin G immunity protein recognizes both
the N-terminal region (residues 1–13) of the a-peptide and
a sequence on the C-terminal side of residue 13 in the
b-peptide (C. Oppega ˚rd et al., in preparation), since these
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Fig. 2 Cartoon representation of the structural model of lactococcin
G and its orientation in target-cell membranes. The two peptides
interact through the G7xxxG11-motif in the a-peptide and the
G18xxxG22-motif in the b-peptide and form a trans-membrane
helix–helix structure. The highly positively charged and structurally
ﬂexible C-terminal end of the a-peptide is forced through the
membrane by the trans-membrane potential (negative inside). The
tryptophan residues in the structurally ﬂexible N-terminal region of
the b-peptide are in or near the outer membrane interface
56 Probiotics & Antimicro. Prot. (2010) 2:52–60
123regions are adjacent to each other in the proposed structure
(Fig. 2) and may consequently interact simultaneously with
the immunity protein.
Structure of Plantaricin E/F
The three-dimensional structures of the E (33 residues) and
F (34 residues) peptides that constitute plantaricin E/F
have also been analyzed by NMR spectroscopy [25]. In
the presence of DPC micelles, the E-peptide forms two
a-helical-like regions (residues 10–21 and 25–31) sepa-
rated by a ﬂexible GxxxG-motif (residues 20–24), whereas
the F-peptide forms one long helix from residue 7 to 32,
with a kink and slightly more ﬂexible region around Pro-20
[25]. It was proposed that the two peptides interact and
form a helix–helix structure involving their GxxxG-motifs
[25]. The E-peptide has two such motifs, G5xxxG9 and
G20xxxG24, while the F-peptide has one, G30xxxG34
(Fig. 1).
It is, however, not clear how these GxxxG-motifs might
combine, and several alternatives have been suggested
[25]. One possibility is that the G30xxxG34-motif in the
F-peptide pairs with the G5xxxG9-motif in the E-peptide.
This pairing is not so likely, however, since it would result
in a very short (not more than 9 residues in length) helix–
helix region if the motifs interacted in a parallel orienta-
tion, and the negatively charged aspartate residues in the
E- and F-peptides (D17 and D22 in the E- and F-peptides,
respectively) would come near each other if they interacted
in an antiparallel orientation [25]. A more likely pairing is
that G20xxxG24 in the E-peptide interacts in a parallel
orientation with G30xxxG34 in the F-peptide, as this will
bring G5xxxG9 in the E-peptide near a ﬂat surface formed
by residues S16, G19, and P20 in the F-peptide [25].
Another possibility is that the ﬂat surface formed by resi-
dues S16, G19, and P20 in the F-peptide interacts with
G20xxxG24 in the E-peptide. Future mutagenesis analysis
of the E- and F-peptides should differentiate between these
alternatives.
Structure of Plantaricin J/K
The three-dimensional structures of the J- (25 residues) and
K- (32 residues) peptides that constitute plantaricin J/K
were recently also analyzed by NMR spectroscopy [59]. In
the presence of membrane-mimicking environments (DPC
micelles or TFE), the J-peptide forms an N-terminal
amphiphilic a-helix between residues 3 and 15, while the
K-peptide forms a central amphiphilic a-helix between
residues 9 and 24. There is one GxxxG-motif (Gly-13 to
Gly-17) in the J-peptide and two (Gly-9 to Gly-13 and Gly-
13 to Gly-17) in the K-peptide (Fig. 1). Testing the activity
of single glycine replacement variants of the two peptides
revealed that replacing glycine residues that are part of the
G13xxxG17-motifs in the J- and K-peptides with large
residues was detrimental, while similar replacements of the
other glycine residues in these two peptides were relatively
well tolerated [59]. These mutagenesis results combined
with the NMR structures of the J- and K-peptides are in
accordance with a structural model in which the two pep-
tides interact and form a helix–helix structure involving
their G13xxxG17-motifs [59]. It was, however, not possible
to deduce which of the two possible peptide orientations,
the parallel or the antiparallel, is the most plausible ori-
entation [59].
Some Bacteriocins Function as Peptide Ligands that
Interact with Membrane-Associated Receptors
Mode-of-action studies on the pediocin-like (class-IIa)
bacteriocins and the one-peptide non-pediocin-like (i.e.,
class-IId) bacteriocin lactococcin A revealed that these
bacteriocins bind to a part of the mannose phosphotrans-
ferase permease (the MptC and/or MptD subunits) that is
embedded in the cell membrane [19]. The study also
revealed that the immunity proteins that protect cells from
these bacteriocins bind strongly to the bacteriocin–perme-
ase complex and thereby prevent bacteriocin-induced
killing [19]. Interactions between these bacteriocins and the
mannose phosphotransferase permease thus apparently
alter the conformation of the permease in a manner that
results in membrane-leakage, and this leakage may be
blocked on the cytosolic side of the membrane by the
binding of an immunity protein to the bacteriocin–perme-
ase complex.
Structure–function analyses of the pediocin-like (class-
IIa) bacteriocins revealed that these bacteriocins contain a
helical region that penetrates into the target-membrane and
is involved in determining the antimicrobial spectrum [21,
22, 24, 28, 36, 40, 64, 66]. The membrane-penetrating helix
may be the structural motif that interacts with the mannose
phosphotransferase system, as 15-mer fragments covering
most of the helix inhibit these bacteriocins in a speciﬁc
manner [23; Haugen et al., to be submitted]. It has indeed
been suggested that helical interactions between peptide
bacteriocins and integrated membrane (transport) proteins
might be a common mechanism whereby peptide bacteri-
ocins cause membrane-leakage [53, 56, 58]. In the case of
two-peptide bacteriocins, this interaction might involve the
trans-membrane helix–helix structure. Such a structure
might interact with an integrated membrane protein in an
analogous fashion as shown to be the case for lactococcin
A and the pediocin-like (class-IIa) bacteriocins [19],
although a membrane-associated receptor for a two-peptide
bacteriocin has yet to be identiﬁed. It has, however, been
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123speculated that the lactococcin G immunity protein inter-
acts with lactococcin G indirectly via a putative lactococ-
cin G receptor in an analogous manner as discussed for the
pediocin-like immunity proteins. The functionality of the
lactococcin G immunity protein is indeed target-cell
dependent (as is the case for the pediocin-like immunity
proteins) and thus requires a cellular component (C. Op-
pega ˚rd, in preparation), and this cellular component could
perhaps be a receptor for lactococcin G.
Although ﬁve two-peptide bacteriocins
3 adopt mainly
helical structures, it should be mentioned that this may not
be the case for all two-peptide bacteriocins. CD and NMR
analyses of the two-peptide bacteriocin brochocin-C sug-
gest a high content of b-sheet structure [30], and this may
possibly also be the case for thermophilin 13, since it has
marked sequence similarity with brochocin-C [46, 47].
However, also these two bacteriocins contain several
GxxxG-motifs that suggest helix–helix interactions
between their complementary peptides. The structures of
brochocin-C and thermophilin 13 must be analyzed in more
detail before it can be concluded whether or not they in fact
have a high content of b-sheet structure.
It is essential that more extensive structural analyses of
two-peptide bacteriocins (and other peptide bacteriocins)
are performed, as this is necessary to attain more certain
and detailed insight into the three-dimensional structure of
these bacteriocins, which in turn should reveal structural
features that are important for their function and potency.
Such insight will be invaluable for future rational design of
bacteriocin variants with properties that make them useful
for medical and biotechnological applications, and may
allow the development of these peptide bacteriocins into
additives for treatment of infections and preservation of
food and animal feed.
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